Analyst firms · J.P. Morgan · GTHX

J.P. Morgan GTHX price target and rating history

G1 Therapeutics Inc. (GTHX) · Health Care

J.P. Morgan rates G1 Therapeutics Inc. (GTHX) Neutral with a $10 price target, as of its latest action on Jan 30, 2023. It has published 3 rating actions on GTHX since September 2021, including 1 upgrade and 2 downgrades.

Current rating
Neutral
Price target
$10
Median target, all firms
Too few
Actions on GTHX
3

J.P. Morgan price target on GTHX

$20$15$1020222023202420252026
J.P. Morgan price target on GTHX, each point a stated target, September 2021 to January 2023.

Every J.P. Morgan rating on GTHX

Questions about J.P. Morgan and GTHX

What is J.P. Morgan's price target for GTHX?
J.P. Morgan's latest stated price target for G1 Therapeutics Inc. (GTHX) is $10, from its action on Jan 30, 2023.
What is J.P. Morgan's rating on GTHX?
J.P. Morgan rates GTHX Neutral, a neutral rating, as of Jan 30, 2023.
When did J.P. Morgan last change its view on GTHX?
On Jan 30, 2023, J.P. Morgan upgrades to Neutral from Underweight, price target $7 to $10.

All J.P. Morgan ratingsGTHX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.